Ionis Catches The Eye With New Roche Alliance

 
• By Kevin Grogan

October has been a very good month for Ionis. Following US approval of Tegredi, it has now signed a potentially lucrative deal with existing partner Roche for another antisense drug, this time to tackle advanced dry AMD.

20/20 Vision
Ionis sees clearer path for dry AMD drug with Roche onboard • Source: Shutterstock

More from Sensory

More from Therapy Areas